ClinicalTrials.Veeva

Menu

Contralateral ReSTOR / Monofocal or Phakic Eye

Alcon logo

Alcon

Status and phase

Completed
Phase 4

Conditions

Cataracts

Treatments

Device: ReSTOR

Study type

Interventional

Funder types

Industry

Identifiers

NCT00731640
M07-012

Details and patient eligibility

About

Bilateral evaluation of unilateral implantation of ReSTOR and contralateral monofocal or phakic eye.

Enrollment

52 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Unilateral operable cataract
  • Candidate for presbyopic intraocular lens (IOL)

Exclusion criteria

  • Ocular comorbidities compromising primary outcome
  • Bilateral cataracts

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

52 participants in 2 patient groups

Monofocal
Active Comparator group
Description:
Patients unilaterally implanted with ReSTOR lens in one eye and previously implanted with monofocal Intraocular lens (IOL) (unspecified) in other eye
Treatment:
Device: ReSTOR
Phakic
Active Comparator group
Description:
Patients unilaterally implanted with ReSTOR lens in one eye and phakic in the other eye with no necessary cataract removal impending
Treatment:
Device: ReSTOR

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems